{
    "2021-07-21": [
        [
            {
                "time": "2021-07-28",
                "original_text": "Dow Jones Up 270 Points After Coca-Cola, Johnson & Johnson, Verizon Announce Earnings",
                "features": {
                    "keywords": [
                        "Dow Jones",
                        "Coca-Cola",
                        "Johnson & Johnson",
                        "Verizon",
                        "Earnings"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "telecommunications",
                        "consumer goods"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-07-29",
                "original_text": "Dow closes up more than 285 points as stocks extend rebound rally",
                "features": {
                    "keywords": [
                        "Dow",
                        "rebound rally",
                        "stocks"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-07-30",
                "original_text": "J&J CFO: Not-for-Profit Vaccine Price Likely to End in 2021",
                "features": {
                    "keywords": [
                        "J&J",
                        "vaccine",
                        "price",
                        "CFO"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-07-30",
                "original_text": "J&J COVID-19 vaccine sales to total $2.5 billion in 2021",
                "features": {
                    "keywords": [
                        "J&J",
                        "COVID-19",
                        "vaccine",
                        "sales"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-07-30",
                "original_text": "US STOCKS-Wall Street rises on upbeat earnings, recovery optimism",
                "features": {
                    "keywords": [
                        "US Stocks",
                        "Wall Street",
                        "earnings",
                        "optimism"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-07-30",
                "original_text": "Coke, J&J, Verizon All Beat on Q2 Numbers",
                "features": {
                    "keywords": [
                        "Coke",
                        "J&J",
                        "Verizon",
                        "Q2 Numbers"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "telecommunications",
                        "consumer goods"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-07-30",
                "original_text": "J&J Stock Rises on Earnings. Study Adds to Doubts Over Its Vaccineâ€™s Efficacy.",
                "features": {
                    "keywords": [
                        "J&J",
                        "Stock",
                        "Earnings",
                        "Vaccine",
                        "Efficacy"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "mixed",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2021-07-30",
                "original_text": "Johnson & Johnson (JNJ) Q2 Earnings and Revenues Top Estimates",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Q2",
                        "Earnings",
                        "Revenues",
                        "Estimates"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}